Automated insulin delivery (AID) systems, also known as hybrid closed loop systems, are changing the way type 1 diabetes is managed. These systems, which combine an insulin pump with a continuous ...

The twiist Automated Insulin Delivery System is now available for adults with insulin-treated type 2 diabetes.

Clearance expands twiist's precise insulin delivery and personalized automation to the largest population of people treated with insulin, with time-in-range improvements seen in as little as one day ...

The newly cleared system is compatible with select continuous glucose monitors, including FreeStyle Libre 3 Plus and ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery (AID) in adults with insulin-treated type 2 diabetes. AID significantly ...

Phase 2a pilot study aims to inform the design and conduct of future Phase 3 research in this populationCadisegliatin is a potential ...

With Twiist already available in Type 1 diabetes, Sequel has made the automated insulin delivery system available for the ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with ...

MANCHESTER, N.H. and GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, and Senseonics Holdings, Inc. (NYSE ...

TORONTO — Automated insulin delivery (AID) systems have revolutionized how people with type 1 diabetes (T1D) manage their glucose levels throughout the day. This technology is also having a big impact ...

At present, the AID is the most advanced form of insulin therapy for T1D. AID involves continuous glucose monitoring (CGM), and an algorithm is adjusted to insulin dosage based on blood glucose levels ...